Senior insider sale
MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$75.0K
3K shares
What this filing means
KARYDAS DAPHNE plans to sell 3K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $75.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/31/2026ACC: 0001964306-26-000192
Director
Since Feb 2026
3K
Shares to sell
$75.0K
Approx. market value
3K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of employee stock options
Broker assisted cashless exercise
3/31/2026
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2026 | Exercise of employee stock options Broker assisted cashless exercise | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3K
Market value
$75.0K
3/31/2026
Total
Units
3K
Value
$75.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/31/2026 | 3K | $75.0K | NASDAQ | Planned |
| Total | 3K | $75.0K | ||